129 related articles for article (PubMed ID: 8003252)
1. Further evidence that human lysosomal sialidase is not derived from prosaposin. Prosaposin biosynthesis and ganglioside sialidase studies in prosaposin- and sialidase-deficient fibroblast lines.
Paton BC; Schneider-Jakob HR; Kopitz J; Harzer K; Poulos A; Cantz M
Biol Chem Hoppe Seyler; 1994 Jan; 375(1):25-9. PubMed ID: 8003252
[TBL] [Abstract][Full Text] [Related]
2. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.
Lieser M; Harms E; Kern H; Bach G; Cantz M
Biochem J; 1989 May; 260(1):69-74. PubMed ID: 2775195
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal and plasma membrane ganglioside GM3 sialidases of cultured human fibroblasts. Differentiation by detergents and inhibitors.
Schneider-Jakob HR; Cantz M
Biol Chem Hoppe Seyler; 1991 Jun; 372(6):443-50. PubMed ID: 1910582
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal sialidase deficiency in sialidosis with partial beta-galactosidase deficiency.
Yamada T; Tsuji S; Ariga T; Miyatake T
Biochim Biophys Acta; 1983 Jan; 755(1):106-11. PubMed ID: 6402033
[TBL] [Abstract][Full Text] [Related]
8. Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies.
Chatelut M; Harzer K; Christomanou H; Feunteun J; Pieraggi MT; Paton BC; Kishimoto Y; O'Brien JS; Basile JP; Thiers JC; Salvayre R; Levade T
Clin Chim Acta; 1997 Jun; 262(1-2):61-76. PubMed ID: 9204210
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation.
Vinogradova MV; Michaud L; Mezentsev AV; Lukong KE; El-Alfy M; Morales CR; Potier M; Pshezhetsky AV
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):641-50. PubMed ID: 9480870
[TBL] [Abstract][Full Text] [Related]
10. The identification of lysosomal ganglioside sialidase in human cells.
Zeigler M; Sury V; Bach G
Eur J Biochem; 1989 Aug; 183(2):455-8. PubMed ID: 2759093
[TBL] [Abstract][Full Text] [Related]
11. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
12. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
13. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
14. The role of lysosomal sialidase and beta-galactosidase in processing the complex carbohydrate chains on lysosomal enzymes and possibly other glycoproteins.
Swallow DM; West LF; Van Elsen A
Ann Hum Genet; 1984 Jul; 48(3):215-21. PubMed ID: 6431895
[TBL] [Abstract][Full Text] [Related]
15. Human placental sialidase complex: characterization of the 60 kDa protein that cross-reacts with anti-saposin antibodies.
Hiraiwa M; Uda Y; Tsuji S; Miyatake T; Martin BM; Tayama M; O'Brien JS; Kishimoto Y
Biochem Biophys Res Commun; 1991 Jun; 177(3):1211-6. PubMed ID: 1905536
[TBL] [Abstract][Full Text] [Related]
16. The relation between human lysosomal beta-galactosidase and its protective protein.
Hoogeveen AT; Verheijen FW; Galjaard H
J Biol Chem; 1983 Oct; 258(20):12143-6. PubMed ID: 6415049
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
[TBL] [Abstract][Full Text] [Related]
18. An activator protein of oligosaccharide sialidase.
Chabás A; Guardiola A; Burguera JM
Biochem Int; 1987 Aug; 15(2):449-57. PubMed ID: 3124850
[TBL] [Abstract][Full Text] [Related]
19. Human neuraminidase is a 60 kDa-processing product of prosaposin.
Potier M; Lamontagne S; Michaud L; Tranchemontagne J
Biochem Biophys Res Commun; 1990 Nov; 173(1):449-56. PubMed ID: 2124114
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
Lamontagne S; Potier M
J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
